PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. - Wikidata - wikimedia - TriplyDB

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

http://www.wikidata.org/entity/Q35052819

about

Huntington's disease: the past, present, and future search for disease modifiers.Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.Laquinimod treatment in the R6/2 mouse model.No evidence of impaired gastric emptying in early Huntington's Disease.Mito-nuclear co-evolution: the positive and negative sides of functional ancient mutations A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.Mitochondrial abnormalities in temporal lobe of autistic brain The role of the immune system in Huntington's disease.Mitochondrial biogenesis and clearance: a balancing act.Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.Complexity of Compensatory Effects in Nrf1 Knockdown: Linking Undeveloped Anxiety-Like Behavior to Prevented Mitochondrial Dysfunction and Oxidative Stress.Mitochondrial Biogenesis in Response to Chromium (VI) Toxicity in Human Liver Cells.Progressive hepatic mitochondrial dysfunction in premanifest Huntington's disease.The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms.Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment.Mitonuclear linkage disequilibrium in human populations.RNA Aptamers Rescue Mitochondrial Dysfunction in a Yeast Model of Huntington’s Disease.Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis Effects of Rhizome Extract of Dioscorea batatas and Its Active Compound, Allantoin, on the Regulation of Myoblast Differentiation and Mitochondrial Biogenesis in C2C12 Myotubes Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3

P2860

Q26830039-2D1E8997-88A4-4F8C-903E-7DB4B7C95879 Q30424048-82DCDD5D-F519-4986-8D65-39830A8C4D5E Q33890346-9B10C039-75AC-4490-BB36-E6CE1AB89170 Q34087126-48E02EEA-64D6-4820-80B6-A12CE0F84EE8 Q34763439-346B721E-6B75-450D-BACB-80B67B44C60D Q35079574-1EA6BA0A-9FE3-45F3-933A-2D838E0205B7 Q37648905-ADB2A3E5-5DAF-4DDD-934F-67610C50DD78 Q38129870-B3678F65-02FB-41A8-ADFE-1BD4D08CE5C9 Q38909954-01A3C099-5BE4-42FF-A8B7-C58F6765BE60 Q39079841-E0A38DE8-F0CE-42E0-900B-58741091E446 Q39427235-FCA6DFB9-B6EC-46D3-A3A9-832D3AAE673F Q40706214-94DA474F-2021-4282-B0F6-CCED629A9043 Q41660581-D9A369D1-EE74-4BDA-8ED1-9473B909C467 Q45298703-C2F1D9AA-2AB9-417D-AC43-3063725943F6 Q49823902-98A7676D-E41C-4FDA-8BB9-BF6942776CCF Q50421506-50871D72-4F7D-4E16-A688-DFF65E697E7E Q52663606-BDB04DCF-65CE-48CA-B54A-B004B94FD1FE Q55414200-7752F7E9-A204-4DB0-A7D1-318EF0F65C20 Q58546890-D881BBFF-2E2A-4020-8E3A-C0465948E1D6 Q58692384-2743BFE3-D249-41CF-8533-7C3EC8201DAE Q58797249-F8C91E9E-D6B7-48AE-9F38-517FF727C267

P2860

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

http://www.wikidata.org/entity/Q35052819

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@ast

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@en

type

label

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@ast

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@en

prefLabel

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@ast

PGC-1alpha downstream transcri ...... difiers of Huntington disease.

@en

P1433

Q35052819-9DCB6027-B299-4025-99B5-06DDE311E355

P1476

Q35052819-7EB5ED8C-6B65-40CF-B807-F0C535535788

P2093

Q35052819-387D63B8-5E88-4A57-8F28-2F62F5A576AC

Q35052819-39694D8D-48B9-4F07-B7F2-0DAC855D2B71

Q35052819-410104BE-4689-4A81-9DA2-149199268BFF

Q35052819-78D89A81-34BF-474D-AB5B-8B935C276907

Q35052819-C9BC3D6C-6F4E-49AF-808C-019B68967143

Q35052819-FF41ECBB-C11D-413B-BB23-AA06015BAE78

P2860

Q35052819-04B7AE5A-E008-462A-9AC3-5DB6361AA3D8

Q35052819-0E128D16-A7BA-40CF-9F8A-FAAD9FF4C30E

Q35052819-154EF725-FB5B-439C-93C3-3EE98526865F

Q35052819-1FD32C2E-6B18-4F4C-9E6E-3DA23C9E3085

Q35052819-29FF7A75-0B24-448C-8C69-9795C109F7D7

Q35052819-32401173-6655-4BE7-8AAE-D74F5D5AEFA1

Q35052819-47DE6F83-963E-4BB8-97B5-2F716C37578C

Q35052819-612C6174-5781-4145-91B9-E37BC7BD64E8

Q35052819-64A241D6-5FDA-44D3-AD4B-163213602E1B

Q35052819-655ECDC2-A3F9-480E-BCF3-633E2DAE242D

P2888

Q35052819-D9FC85C6-78AC-40B0-B948-783C92FD967B

P304

Q35052819-F71CE9CF-22E3-43AB-9255-7B1648621D84

P31

Q35052819-33EC8599-C9ED-4295-A8A0-EB227EB3213C

P356

Q35052819-01ED8A82-639F-4C87-935B-B7313A8BAB85

P433

Q35052819-9C7260DB-7304-429C-B328-A54B68C1ED3B

P478

Q35052819-9F7E44A2-144E-4B62-BACA-F739DDB159ED

P50

Q35052819-1A166676-C2B2-4479-A921-2F93BF95B859

Q35052819-BAD6AE23-AF52-4D9F-9BE7-5331B2051F16

P577

Q35052819-EE1F6A7C-4788-4751-B080-641E8887D5A4

P5875

Q35052819-12863CCB-8720-4D56-BB80-068EDC4B9B70

P6179

Q35052819-0FB571AE-179B-424B-88F6-5CB8B850FEA1

P698

Q35052819-253B30C3-56B6-472A-BF24-CC27322B807C

P921

Q35052819-182608FD-2473-4747-90FB-B54E7B140013

P932

Q35052819-EC8143B0-0E33-473A-ABD3-AAEB0C050523

P356

P1433

Molecular Neurodegeneration

P1476

PGC-1alpha downstream transcri ...... odifiers of Huntington disease

@en

P2093

Aiden Haghikia

http://www.w3.org/2001/XMLSchema#string

Andrew Chan

http://www.w3.org/2001/XMLSchema#string

Denis A Akkad

http://www.w3.org/2001/XMLSchema#string

Elahe Taherzadeh-Fard

http://www.w3.org/2001/XMLSchema#string

Larissa Arning

http://www.w3.org/2001/XMLSchema#string

Stefan Wieczorek

http://www.w3.org/2001/XMLSchema#string

P2860

Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis

The structure of haplotype blocks in the human genome

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice

Physical activity as a metabolic stressor.

Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation.

Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network

Trinucleotide repeat length instability and age of onset in Huntington's disease.

P2888

P304

32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1326-6-32

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Joerg T. Epplen

P577

2011-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51149792

http://www.w3.org/2001/XMLSchema#string

P6179

1053278022

http://www.w3.org/2001/XMLSchema#string

P698

21595933

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3117738

http://www.w3.org/2001/XMLSchema#string